Medical Editor: John P. Cunha, DO, FACOEP
Avaclyr (acyclovir ophthalmic ointment) is a herpes simplex virus nucleoside analog DNA polymerase inhibitor indicated in the treatment of acute herpetic keratitis (dendritic ulcers) in patients with herpes simplex (HSV-1 and HSV-2) virus. Common side effects of Avaclyr include:
- eye pain (stinging),
- inflammation of the cornea (punctate keratitis), and
- eye infection (follicular conjunctivitis).
The dose of Avaclyr is a 1 cm ribbon applied in the lower cul-de-sac of the affected eye 5 times per day until healed then 3 times per day for 7 days. Avaclyr may interact with other drugs. Tell your doctor all medications and supplements you use. Tell your doctor if you are pregnant or plan to become pregnant before using Avaclyr; it is not expected to harm a fetus. Acyclovir, the medication in Avaclyr, passes into breast milk following oral administration. It is unknown if Avaclyr passes into breast milk following ocular administration. Consult your doctor before breastfeeding.
Our Avaclyr (acyclovir ophthalmic ointment) 3% for Topical Ophthalmic Use Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
The most common adverse reactions (2-10%) reported in patients were eye pain (stinging), punctuate keratitis and follicular conjunctivitis. Rare reports of blepharitis and very rare reports of immediate hypersensitivity reactions including angioedema and urticaria have been observed post-marketing in patients taking AVACLYR.
Read the entire FDA prescribing information for Avaclyr (Acyclovir Ophthalmic Ointment)